BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20351091)

  • 21. ErbB2, FoxM1 and 14-3-3ζ prime breast cancer cells for invasion in response to ionizing radiation.
    Kambach DM; Sodi VL; Lelkes PI; Azizkhan-Clifford J; Reginato MJ
    Oncogene; 2014 Jan; 33(5):589-98. PubMed ID: 23318431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MnSOD promotes tumor invasion via upregulation of FoxM1-MMP2 axis and related with poor survival and relapse in lung adenocarcinomas.
    Chen PM; Wu TC; Shieh SH; Wu YH; Li MC; Sheu GT; Cheng YW; Chen CY; Lee H
    Mol Cancer Res; 2013 Mar; 11(3):261-71. PubMed ID: 23271813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells.
    Wang Z; Banerjee S; Kong D; Li Y; Sarkar FH
    Cancer Res; 2007 Sep; 67(17):8293-300. PubMed ID: 17804744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two-fold elevation of expression of FoxM1 transcription factor in mouse embryonic fibroblasts enhances cell cycle checkpoint activity by stimulating p21 and Chk1 transcription.
    Tan Y; Chen Y; Yu L; Zhu H; Meng X; Huang X; Meng L; Ding M; Wang Z; Shan L
    Cell Prolif; 2010 Oct; 43(5):494-504. PubMed ID: 20887555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FoxM1 transactivates PTTG1 and promotes colorectal cancer cell migration and invasion.
    Zheng Y; Guo J; Zhou J; Lu J; Chen Q; Zhang C; Qing C; Koeffler HP; Tong Y
    BMC Med Genomics; 2015 Aug; 8():49. PubMed ID: 26264222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC.
    Calvisi DF; Pinna F; Ladu S; Pellegrino R; Simile MM; Frau M; De Miglio MR; Tomasi ML; Sanna V; Muroni MR; Feo F; Pascale RM
    Gut; 2009 May; 58(5):679-87. PubMed ID: 19136513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MED28 and forkhead box M1 (FOXM1) mediate matrix metalloproteinase 2 (MMP2)-dependent cellular migration in human nonsmall cell lung cancer (NSCLC) cells.
    Hsieh NT; Huang CY; Li CC; Wang IC; Lee MF
    J Cell Physiol; 2019 Jul; 234(7):11265-11275. PubMed ID: 30499104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells.
    Wang D; Hu G; Du Y; Zhang C; Lu Q; Lv N; Luo S
    J Exp Clin Cancer Res; 2017 Feb; 36(1):23. PubMed ID: 28148279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma.
    Bellelli R; Castellone MD; Garcia-Rostan G; Ugolini C; Nucera C; Sadow PM; Nappi TC; Salerno P; Cantisani MC; Basolo F; Gago TA; Salvatore G; Santoro M
    Endocr Relat Cancer; 2012 Oct; 19(5):695-710. PubMed ID: 22919068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CXCL12-induced upregulation of FOXM1 expression promotes human glioblastoma cell invasion.
    Wang S; Zhang S; Li J; Xu X; Weng Y; Zheng M; Ouyang L; Li F
    Biochem Biophys Res Commun; 2014 Apr; 447(1):1-6. PubMed ID: 24561124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression.
    Kwok JM; Myatt SS; Marson CM; Coombes RC; Constantinidou D; Lam EW
    Mol Cancer Ther; 2008 Jul; 7(7):2022-32. PubMed ID: 18645012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway.
    Yu C; Chen L; Yie L; Wei L; Wen T; Liu Y; Chen H
    Oncol Rep; 2015 May; 33(5):2402-10. PubMed ID: 25738652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial cell-specific deletion of transcription factor FoxM1 increases urethane-induced lung carcinogenesis.
    Balli D; Zhang Y; Snyder J; Kalinichenko VV; Kalin TV
    Cancer Res; 2011 Jan; 71(1):40-50. PubMed ID: 21199796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FoxM1 and its association with matrix metalloproteinases (MMP) signaling pathway in papillary thyroid carcinoma.
    Ahmed M; Uddin S; Hussain AR; Alyan A; Jehan Z; Al-Dayel F; Al-Nuaim A; Al-Sobhi S; Amin T; Bavi P; Al-Kuraya KS
    J Clin Endocrinol Metab; 2012 Jan; 97(1):E1-E13. PubMed ID: 22049175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FoxM1 regulates growth factor-induced expression of kinase-interacting stathmin (KIS) to promote cell cycle progression.
    Petrovic V; Costa RH; Lau LF; Raychaudhuri P; Tyner AL
    J Biol Chem; 2008 Jan; 283(1):453-460. PubMed ID: 17984092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation.
    Gemenetzidis E; Bose A; Riaz AM; Chaplin T; Young BD; Ali M; Sugden D; Thurlow JK; Cheong SC; Teo SH; Wan H; Waseem A; Parkinson EK; Fortune F; Teh MT
    PLoS One; 2009; 4(3):e4849. PubMed ID: 19287496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FOXM1 is a therapeutic target for high-risk multiple myeloma.
    Gu C; Yang Y; Sompallae R; Xu H; Tompkins VS; Holman C; Hose D; Goldschmidt H; Tricot G; Zhan F; Janz S
    Leukemia; 2016 Apr; 30(4):873-82. PubMed ID: 26648534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxiredoxin II promotes hepatic tumorigenesis through cooperation with Ras/Forkhead box M1 signaling pathway.
    Park YH; Kim SU; Kwon TH; Kim JM; Song IS; Shin HJ; Lee BK; Bang DH; Lee SJ; Lee DS; Chang KT; Kim BY; Yu DY
    Oncogene; 2016 Jul; 35(27):3503-13. PubMed ID: 26500057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer cells.
    Madureira PA; Varshochi R; Constantinidou D; Francis RE; Coombes RC; Yao KM; Lam EW
    J Biol Chem; 2006 Sep; 281(35):25167-76. PubMed ID: 16809346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer.
    McGovern UB; Francis RE; Peck B; Guest SK; Wang J; Myatt SS; Krol J; Kwok JM; Polychronis A; Coombes RC; Lam EW
    Mol Cancer Ther; 2009 Mar; 8(3):582-91. PubMed ID: 19276163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.